Magnera Announces Participation at the Gabelli Funds 17th Annual Specialty Chemical Symposium
MWN-AI** Summary
Magnera Corporation (NYSE: MAGN) has announced its participation in the Gabelli Funds 17th Annual Specialty Chemical Symposium, scheduled for March 19, 2026, in New York City. Robert Weilminster, the company's Executive Vice President of Corporate Development, Investor Relations, and Strategy, will deliver a presentation at 2:00 p.m. ET, focusing on the latest developments within the company and the specialty chemicals industry. Additionally, Weilminster will conduct one-on-one and small group meetings with institutional investors throughout the day, providing a platform for deeper engagement and discussion about Magnera's strategic initiatives and business outlook.
With over 160 years of experience, Magnera provides a broad range of material solutions to over 1,000 customers worldwide. Their extensive product portfolio includes components used in absorbent hygiene products, protective apparel, specialty construction products, and items serving the food and beverage industry. Currently operating across 45 global manufacturing facilities and employing more than 8,500 individuals, Magnera emphasizes its commitment to innovation and customer partnership, consistently adapting to challenges such as economic fluctuations and evolving market needs.
As part of their investor communications, Magnera also issues forward-looking statements regarding their financial condition, operational expectations, and industry trends. These statements underline the company's proactive approach and strategic vision, while also acknowledging the inherent risks and uncertainties that may affect future performance.
Investors and interested parties can access the live webcast of the presentation by visiting the Gabelli conference website. For further corporate updates and information, stakeholders are encouraged to visit Magnera's official website and follow the company on social media channels.
MWN-AI** Analysis
Magnera Corporation (NYSE: MAGN) has made a significant announcement by participating in the Gabelli Funds 17th Annual Specialty Chemical Symposium, which could be a pivotal event for investors and market analysts alike. Scheduled for March 19, 2026, this symposium presents an opportunity for Magnera to showcase its diverse product offerings and corporate strategies to institutional investors. The presentation by Robert Weilminster, EVP of Corporate Development, will provide insights into the company’s performance and future outlook, a critical aspect for stakeholders looking to evaluate investment potential.
Given Magnera’s extensive portfolio, serving over 1,000 customers globally across various sectors, including hygiene, construction, and food and beverage, the company appears well-positioned to capitalize on evolving market demands. The fact that Magnera has maintained operations through economic uncertainties and global challenges reinforces its resilience and strategic adaptability. As Magnera enters this conference, it is essential for investors to closely monitor the insights shared during the presentation, especially concerning growth strategies and future revenue projections.
From a market perspective, Magnera’s robust production capacity and global footprint could translate into favorable growth dynamics post-conference. However, potential investors should remain cautious and aware of the forward-looking statements made, as these involve risks and uncertainties that could impact future performance. Staying informed about these risks, as outlined in their SEC filings, is crucial for informed decision-making.
In summary, keeping a close watch on Magnera’s participation in the symposium and subsequent developments will provide valuable context for evaluating its investment potential. Engaging with the post-conference analysis and leveraging insights from institutional interactions will further guide investment strategies in this multifaceted market landscape.
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
CHARLOTTE, N.C., March 06, 2026 (GLOBE NEWSWIRE) -- Magnera Corporation (NYSE: MAGN) today announced they will attend the Gabelli Funds 17th Annual Specialty Chemical Symposium in New York, NY on Thursday, March 19, 2026. Magnera EVP, Corporate Development, Investor Relations & Strategy, Robert Weilminster, will present during the conference on Thursday, March 19 at 2:00 p.m. ET. He will also host 1x1 and small group meetings with institutional investors throughout the day on Thursday, March 19, 2026.
To register for the live webcast of the presentation please visit:
https://gabelli.com/event/17th-annual-chemical-conference/
About Magnera
Magnera Corporation (NYSE: MAGN) serves 1,000+ customers worldwide, offering a wide range of material solutions, including components for absorbent hygiene products, protective apparel, wipes, specialty building and construction products, and products serving the food and beverage industry. Operating across 45 global production facilities, Magnera is supported by over 8,500 employees.
Magnera’s purpose is to better the world with new possibilities made real. For more than 160 years, the company has delivered the material solutions their partners need to thrive. Through economic upheaval, global pandemics and changing end-user needs, Magnera has consistently found ways to solve problems and exceed expectations. The distinct scale and comprehensive portfolio of Magnera’s products brings customers more materials and choices. Magnera builds personal partnerships that withstand an ever-changing world.
Visit magnera.com for more information and follow @MagneraCorporation on social platforms.
Forward-Looking Statements
Information included or incorporated by reference in Magnera Corporation’s filings with the U.S. Securities and Exchange Commission (the “SEC”) and press releases or other public statements contain or may contain “forward-looking” statements with the meaning of the federal securities laws and are presented pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Such “forward-looking” statements include, but are not limited to, statements with respect to our financial condition, results of operations and business, our expectations or beliefs concerning future events, statements about future financial and operating results, the company’s plans, objectives, expectations and intentions and other statements that are not historical facts. These statements contain words such as “believes,” “expects,” “may,” “will,” “should,” “would,” “could,” “seeks,” “approximately,” “intends,” “plans,” “estimates,” “projects,” “outlook,” “anticipates,” or “looking forward” or similar expressions that relate to our strategy, plans, intentions or expectations. All statements we make relating to our estimated and projected earnings, margins, costs, expenditures, cash flows, growth rates, and financial results or to our expectations regarding future industry trends are forward-looking statements. In addition, we, through our senior management, from time to time make forward-looking public statements concerning our expected future operations and performance and other developments. These forward-looking statements are based upon the current beliefs and expectations of the management of Magnera and are subject to risks and uncertainties that may change at any time, and, therefore, our actual results may differ materially from those that we expected. These risks and other risk factors are detailed from time to time in Magnera’s reports filed with the SEC, including annual report on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K, including our Form 8-K/A filed on January 31, 2025, and other documents filed with the SEC. These risk factors may not contain all of the material factors that are important to you. New factors may emerge from time to time and it is not possible to either predict new factors or assess the potential effect of any such new factors. Accordingly, readers should not place undue reliance on those statements. All forward-looking statements are based upon information available as of the date hereof. All forward-looking statements are made only as of the date hereof, and we undertake no obligation to publicly update or revise any forward-looking statements as a result of new information, future events, or otherwise, except as otherwise required by law.
Investor Contact:
Robert Weilminster
ir@magnera.com
FAQ**
How will the insights shared by Robert Weilminster at the Gabelli Funds 17th Annual Specialty Chemical Symposium impact investor perceptions of Magnera Corporation MAGN's growth potential and market position?
What specific strategies is Magnera Corporation MAGN pursuing to adapt to changing end-user needs, particularly in the specialty chemical sector highlighted at the upcoming symposium?
With over 1,000 customers worldwide, how does Magnera Corporation MAGN plan to further expand its customer base and enhance its product offerings in the coming years?
In light of the risks mentioned in the forward-looking statements, what measures is Magnera Corporation MAGN undertaking to mitigate potential uncertainties affecting its future performance?
**MWN-AI FAQ is based on asking OpenAI questions about Magnera Corporation (NYSE: MAGN).
NASDAQ: MAGN
MAGN Trading
-1.66% G/L:
$10.67 Last:
141,448 Volume:
$10.74 Open:
